ACE2 and COVID-19: An increase in ACE2 expression is not harmful to the patient as shown by the demonstration that ACE inhibitors, which increase ACE2 expression, do not increase the susceptibility to COVID-19 nor SARS-Cov-2 host cell entry and propagation (81, 82).